1. Weiskopf N, Edwards LJ, Helms G, Mohammadi S, Kirilina E. Quantitative magnetic resonance imaging of brain anatomy and in vivo histology. Nature Reviews Physics 2021;3:570–588.
2. Hamilton-Craig CR, Strudwick MW, Galloway GJ. T1 Mapping for Myocardial Fibrosis by Cardiac Magnetic Resonance Relaxometry—A Comprehensive Technical Review. Frontiers in Cardiovascular Medicine 2017;3:49.
3. MacKay AL, Vavasour IM, Rauscher A, et al. MR relaxation in multiple sclerosis. Neuroimaging Clin. N. Am. 2009;19:1–26.
4. Liao C, Wang K, Cao X, et al. Detection of Lesions in Mesial Temporal Lobe Epilepsy by Using MR Fingerprinting. Radiology 2018;288:804–812.
5. Recht MP, Resnick D. Magnetic resonance imaging of articular cartilage: an overview. Top. Magn. Reson. Imaging 1998;9:328–336.
6. Ma D, Jones SE, Deshmane A, et al. Development of high-resolution 3D MR fingerprinting for detection and characterization of epileptic lesions. J. Magn. Reson. Imaging 2019;49:1333–1346.
7. Shin H-G, Lee J, Yun YH, et al. χ-separation: Magnetic susceptibility source separation toward iron and myelin mapping in the brain. Neuroimage 2021;240:118371.
8. Chen J, Gong N-J, Chaim KT, Otaduy MCG, Liu C. Decompose quantitative susceptibility mapping (QSM) to sub-voxel diamagnetic and paramagnetic components based on gradient-echo MRI data. Neuroimage 2021;242:118477.
9. Emmerich J, Bachert P, Ladd ME, Straub S. On the separation of susceptibility sources in quantitative susceptibility mapping: Theory and phantom validation with an in vivo application to multiple sclerosis lesions of different age. Journal of Magnetic Resonance 2021;330:107033 doi: 10.1016/j.jmr.2021.107033. [doi]
10. Kvernby S, Warntjes MJB, Haraldsson H, Carlhäll C-J, Engvall J, Ebbers T. Simultaneous three-dimensional myocardial T1 and T2 mapping in one breath hold with 3D-QALAS. J. Cardiovasc. Magn. Reson. 2014;16:102.
11. Fujita S, Hagiwara A, Hori M, et al. Three-dimensional high-resolution simultaneous quantitative mapping of the whole brain with 3D-QALAS: An accuracy and repeatability study. Magn. Reson. Imaging 2019;63:235–243.
12. Mugler JP, Brookeman JR. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magnetic Resonance in Medicine 1990;15:152–157 doi: 10.1002/mrm.1910150117. [doi]
14. Haacke EM, Xu Y, Cheng Y-CN, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 2004;52:612–618.
15. Li W, Wu B, Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage 2011;55:1645–1656.
16. Schweser F, Deistung A, Lehr BW, Reichenbach JR. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage 2011;54:2789–2807.
17. Wu B, Li W, Guidon A, Liu C. Whole brain susceptibility mapping using compressed sensing. Magn. Reson. Med. 2012;67:137–147.
18. de Rochefort L, Liu T, Kressler B, et al. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn. Reson. Med. 2010;63:194–206.
19. Liu J, Liu T, de Rochefort L, et al. Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 2012;59:2560–2568.
20. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn. Reson. Med. 2002;47:1202–1210.
21. Wei H, Dibb R, Zhou Y, et al. Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range. NMR Biomed. 2015;28:1294–1303.